CClinicalTrials.gg
CompletedNCT02839174Updated Jun 9, 2017

Type One Diabetes and Low Carb Study

An observational study in Diabetes Mellitus, Type 1, sponsored by Boston Children's Hospital. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2017-06-09.

Sponsored by Boston Children's Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
340
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The investigators have identified a support group on social media with \~1500 members (children and adults), the majority of whom have T1DM and follow a carbohydrate-restricted diet. Many participants report exceptionally low HbA1C and insulin requirements. If these anecdotal reports are reflective of a large group of people with type 1 diabetes, a clinical trial would be warranted.

The investigators propose to survey the above-mentioned group and their professional diabetes care providers to characterize glycemic control and explore associated dietary and diabetes care factors.

Read the detailed description

The surveys will address questions in the following domains: 1) Diabetes diagnosis and treatment; 2) Carbohydrate-restricted diet; 3) Insulin regimen; 4) Other diabetes related care; 5) Diabetes complications; 6) Other related health and healthcare; 7) Patient provider interactions; 8) Socio-demographics. Drafts of these surveys are included in the appendix of this protocol.

02

Conditions studied

  • Diabetes Mellitus, Type 1

Keywords

  • low carbohydrate diet
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 340 is above the median of 233 across 2,220 observational studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Boston Children's Hospital is the lead sponsor of 598 studies on the registry; 151 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The social media group on Facebook, TYPEONEGRIT, includes approximately 1500 members, the majority of whom reportedly have type 1 diabetes and follow a carbohydrate-restricted diet.

Inclusion criteria

  • Adult patients with a diagnosis of T1DM who are currently on insulin treatment or
  • Adults who are a parent or guardian of a child with T1DM who is currently on insulin treatment and
  • Self-reported use of a regimen including carbohydrate restriction for at least 3 months

Exclusion criteria

Exclusion Criteria:

  • Women who are pregnant or breastfeeding.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
340 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Hemoglobin A1C

    self reported, confirmed by professional diabetes care provider if possible

    Time frame: within 3 month of taking the survey

Secondary outcomes

  1. total daily insulin dose

    self reported, confirmed by professional diabetes care provider if possible

    Time frame: within 3 month of taking the survey

  2. total daily dietary carbohydrate

    self reported

    Time frame: within 3 month of taking the survey

  3. diabetes-related complication rates - diabetic ketoacidosis, hypoglycemia

    Time frame: timeframe since staring low carb diet (at least three months)

  4. BMI

    self reported, confirmed by professional diabetes care provider if possible

    Time frame: within 3 month of taking the survey

  5. change in HbA1C

    self reported, confirmed by professional diabetes care provider if possible

    Time frame: current (within three months of taking the survey) - baseline (last available pre-carbohydrate-restricted diet)

  6. patient-physician relationship

    self reported, complemented by professional diabetes care provider if possible

    Time frame: within 3 month of taking the survey

07

Study locations

1 site
  • Boston Children's Hospital
    Boston, Massachusetts 02115, United States
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified data will be shared with external collaborators.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02839174
Lead sponsor
Boston Children's Hospital
Responsible party
Belinda Lennerz (Instructor in Pediatric Endocrinology, Boston Children's Hospital) — Principal investigator
First posted
Jul 20, 2016
Start date
Sep 2016
Primary completion
Jan 2017
Completion
Mar 2017
Last update
Jun 9, 2017

Study contacts

Belinda Lennerz
principal investigator · Boston Children's Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion